Heart : official journal of the British Cardiac Society
-
Randomized Controlled Trial Comparative Study
Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery.
Ticagrelor was shown to reduce mortality in patients who underwent coronary artery bypass grafting (CABG), but its effect on graft patency is unknown. ⋯ Ticagrelor added to aspirin after CABG reduced the proportion of patients with graft occlusion, and was a significant univariate and multivariable predictor of graft occlusion. These results are hypothesis-generating and should be confirmed in larger studies.